Sort
8,912 grants matching “sars cov 2”
The effects of immunosuppression on SARS-CoV-2 persistence, virus genetic diversity and clinical outcomes of COVID-19
$296,625Mirella Salvatore · Weill Medical Coll Of Cornell Univ · R21 · FY2024 · AI
Partnership for Research in Emerging Viral Infections-Sierra Leone (PREVSL)
$296,608John Scribner Schieffelin · Tulane University Of Louisiana · D43 · FY2025 · TW
PROmotion of COVid-19 VA(X)ccination in the Emergency Department - PROCOVAXED
$296,241Robert Rodriguez · University Of California, San Francisco · R01 · FY2023 · AI
Structure-guided neutralizing antibodies developed using EpiVolve technology
$296,100Xiaofeng Li · Abbratech, Inc. · R44 · FY2023 · AI
Multivalent protein-DNA nanostructures as synthetic blocking antibodies
$296,022Nicholas Stephanopoulos · Arizona State University-Tempe Campus · R01 · FY2023 · GM
CoVPN 5002: SARS-CoV-2 Prevalence Study
$295,993Deborah J Donnell · Fred Hutchinson Cancer Research Center · UM1 · FY2020 · AI
Supplement to U01CA260469
$295,988Todd William Lucas · Michigan State University · U01 · FY2024 · CA
Targeting Covid-19 with a Therapeutic Interfering Particle
$295,928Raul Andino · Aleph Therapeutics, Inc. · R41 · FY2022 · AI
Development and Deployment of an Electrochemical Antigen Testing System for SARS-CoV-2
$295,888Shana O Kelley · University Of Toronto · R21 · FY2021 · EB
A Novel, Host-Directed Therapeutic for the Treatment of Sulfur Mustard Induced Lung Injury
$295,715Livia Agnes Veress · Cmtx Biotech, Inc. · R41 · FY2025 · AI
CORE 3 : Modeling Core
$295,573Trey Ideker · University Of California, San Francisco · U19 · FY2025 · AI
Alphavirus Vectored Vaccines for the SARS Coronavirus
$295,521Robert E. Johnston · Univ Of North Carolina Chapel Hill · P01 · FY2009 · AI
Animal/Virology Core
$295,245Stanley Perlman · University Of Iowa · P01 · FY2018 · AI
Preclinical development of a Nipah Virus inhibitor
$295,096Sean Ekins · Collaborations Pharmaceuticals, Inc. · R43 · FY2023 · AI
SARS-CoV-2 Diagnostic/Prognostic Sequencing Method
$295,079Douglas Bell · National Institute Of Environmental Health Sciences · ZIA · FY2023 · ES
SBIR Phase I: A Versatile Nucleic Acid Collection and Purification Technology for Wastewater-Based Epidemiology
$295,000Kyle King · Frontline Biotechnologies Inc. · · FY2023 · TIP
Training in Infectious Diseases in Peru - Time for Implementation Research
$294,960Hector Hugo Garcia · Universidad Peruana Cayetano Heredia · D43 · FY2021 · TW
Capless mRNA for use as a vaccine
$294,877Brian W Fouty · Compovax, Llc · R41 · FY2024 · AI
Prenatal and Early Childhood Pathways To Health: An Integrated Model of Chemical and Social
$294,760Catherine J Karr · University Of Washington · UH3 · FY2020 · OD
Healthcare Modeling Workforce Development Through Washington State University's Resistance Epidemiology Modeling Initiative
$294,683Eric T Lofgren · Washington State University · U01 · FY2022 · CK
CORE 3 : Modeling Core
$294,562Trey Ideker · University Of California, San Francisco · U19 · FY2024 · AI
RAPID ACCELERATION OF DIAGNOSTICS (RADX) PROGRAM: TECH PROJECT #2244: EASY TO USE, LOW-COST MOLECULAR-BASED SARS-COV-2 TEST, HIGHLY SCALABLE
$294,500Ingo Chakravarty · · N02 · FY2021 · HL
Core 06: Biomedical Informatics Core
$294,412Lucio Miele · Lsu Pennington Biomedical Research Ctr · U54 · FY2023 · GM
Immune response to COVID-19 vaccination in individuals with immune disorders
$294,282Emily Ricotta · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
EAGER: Engineering Optical Nanobiosensors for Detection of Coronavirus Proteases
$294,100Stefan H Bossmann · University Of Kansas Medical Center Research Institute Inc · · FY2021 · ENG